ABVC BioPharma, Inc. (ABVC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 49.54M |
| Enterprise Value | 52.33M |
| P/E Ratio | -3.02 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | -29.07 |
| Price/Book Ratio | 2.25 |
| Enterprise/Revenue | -31.24 |
| Enterprise/EBITDA | -3.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 9.93 |
| Operating Margin | 9.19 |
AD
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | -0.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | -0.03 |
| Gross Profit | 0 |
| EBITDA | -7.43M |
| Net Income | -7.91M |
| Diluted EPS | -0.39 |
Balance Sheet
| Total Cash | 94,364 |
| Total Cash/Share | 0 |
| Total Debt | 1.76M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 0.07 |
| Book Value Per Share | 0.47 |
Price History
| 52-Week Change | -72.28 |
| 52-Week High | 3.4 |
| 52-Week Low | 0.82 |
| Moving Average 50 Days | 1.24 |
| Moving Average 200 Days | 1.61 |
Statistics
| Average Volume | 143,625 |
| Shares Outstanding | 26M |
| % Held by Institutions | 1.78 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 25, 2023 |
AD
